Stapled peptides

Providing the best of both worlds in drug development

Xiayang Xie, Lixia Gao, Austin Y. Shull, Yong Teng

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Peptide-based drug discovery has experienced a remarkable resurgence within the past decade due to the emerging class of inhibitors known as stapled peptides. Stapled peptides are therapeutic protein mimetics that have been locked within a specific conformational structure by hydrocarbon stapling. These peptides are highly important in selectively impairing disease-relevant protein-protein interactions and exhibit significant pharmacokinetic advantages over other forms of therapeutics in terms of affinity, specificity, size, synthetic accessibility and resistance to proteolytic degradation. A series of stapled peptides are currently in development, and the potential successes of these peptides, either as single-agent treatments or as combinational treatments with other therapeutic modalities, could potentially change the landscape of protein therapeutic development. Here, we provide examples of successful discovery efforts to illustrate the research strategies of stapled peptides in drug design and development.

Original languageEnglish (US)
Pages (from-to)1969-1980
Number of pages12
JournalFuture Medicinal Chemistry
Volume8
Issue number16
DOIs
StatePublished - Oct 1 2016

Fingerprint

Peptides
Pharmaceutical Preparations
Proteins
Drug Design
Drug Discovery
Therapeutics
Hydrocarbons
Pharmacokinetics
Research

Keywords

  • drug development
  • protein-protein interactions
  • stapled peptides

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

Stapled peptides : Providing the best of both worlds in drug development. / Xie, Xiayang; Gao, Lixia; Shull, Austin Y.; Teng, Yong.

In: Future Medicinal Chemistry, Vol. 8, No. 16, 01.10.2016, p. 1969-1980.

Research output: Contribution to journalReview article

Xie, Xiayang ; Gao, Lixia ; Shull, Austin Y. ; Teng, Yong. / Stapled peptides : Providing the best of both worlds in drug development. In: Future Medicinal Chemistry. 2016 ; Vol. 8, No. 16. pp. 1969-1980.
@article{e04f46f3862d4f2d800d8f03846b9e86,
title = "Stapled peptides: Providing the best of both worlds in drug development",
abstract = "Peptide-based drug discovery has experienced a remarkable resurgence within the past decade due to the emerging class of inhibitors known as stapled peptides. Stapled peptides are therapeutic protein mimetics that have been locked within a specific conformational structure by hydrocarbon stapling. These peptides are highly important in selectively impairing disease-relevant protein-protein interactions and exhibit significant pharmacokinetic advantages over other forms of therapeutics in terms of affinity, specificity, size, synthetic accessibility and resistance to proteolytic degradation. A series of stapled peptides are currently in development, and the potential successes of these peptides, either as single-agent treatments or as combinational treatments with other therapeutic modalities, could potentially change the landscape of protein therapeutic development. Here, we provide examples of successful discovery efforts to illustrate the research strategies of stapled peptides in drug design and development.",
keywords = "drug development, protein-protein interactions, stapled peptides",
author = "Xiayang Xie and Lixia Gao and Shull, {Austin Y.} and Yong Teng",
year = "2016",
month = "10",
day = "1",
doi = "10.4155/fmc-2016-0102",
language = "English (US)",
volume = "8",
pages = "1969--1980",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science",
number = "16",

}

TY - JOUR

T1 - Stapled peptides

T2 - Providing the best of both worlds in drug development

AU - Xie, Xiayang

AU - Gao, Lixia

AU - Shull, Austin Y.

AU - Teng, Yong

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Peptide-based drug discovery has experienced a remarkable resurgence within the past decade due to the emerging class of inhibitors known as stapled peptides. Stapled peptides are therapeutic protein mimetics that have been locked within a specific conformational structure by hydrocarbon stapling. These peptides are highly important in selectively impairing disease-relevant protein-protein interactions and exhibit significant pharmacokinetic advantages over other forms of therapeutics in terms of affinity, specificity, size, synthetic accessibility and resistance to proteolytic degradation. A series of stapled peptides are currently in development, and the potential successes of these peptides, either as single-agent treatments or as combinational treatments with other therapeutic modalities, could potentially change the landscape of protein therapeutic development. Here, we provide examples of successful discovery efforts to illustrate the research strategies of stapled peptides in drug design and development.

AB - Peptide-based drug discovery has experienced a remarkable resurgence within the past decade due to the emerging class of inhibitors known as stapled peptides. Stapled peptides are therapeutic protein mimetics that have been locked within a specific conformational structure by hydrocarbon stapling. These peptides are highly important in selectively impairing disease-relevant protein-protein interactions and exhibit significant pharmacokinetic advantages over other forms of therapeutics in terms of affinity, specificity, size, synthetic accessibility and resistance to proteolytic degradation. A series of stapled peptides are currently in development, and the potential successes of these peptides, either as single-agent treatments or as combinational treatments with other therapeutic modalities, could potentially change the landscape of protein therapeutic development. Here, we provide examples of successful discovery efforts to illustrate the research strategies of stapled peptides in drug design and development.

KW - drug development

KW - protein-protein interactions

KW - stapled peptides

UR - http://www.scopus.com/inward/record.url?scp=84989846932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989846932&partnerID=8YFLogxK

U2 - 10.4155/fmc-2016-0102

DO - 10.4155/fmc-2016-0102

M3 - Review article

VL - 8

SP - 1969

EP - 1980

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 16

ER -